Literature DB >> 11860270

Preferential transfection of adult mouse neural stem cells and their immediate progeny in vivo with polyethylenimine.

Gregory F Lemkine1, Stefano Mantero, Carole Migné, Aicha Raji, Daniel Goula, Priscilla Normandie, Giovanni Levi, Barbara A Demeneix.   

Abstract

The subventricular zone of the adult mammalian brain harbors the neural stem cell population with potential neural regeneration and repair capacity. We describe a nonviral technique to preferentially transfect in vivo the adult neural stem cell population and its immediate progeny based on intraventricular injection of PEI/DNA complexes. The transfected population was identified by cellular and ultra-structural evidence showing their proliferating status and expression of the specific markers GFAP and nestin. Stable activation of the lacZ reporter by cre-recombinase transfection in R26R mice demonstrated survival and migration of stem cell derivatives three months after injection. Apoptosis is thought to be the most common fate of the stem cell progeny. Overexpression of Bcl-X(L) increased number and survival time of transduced progenitors and decreased the frequency of cells immunopositive for activated Caspase-3. This method thus provides selective targeting of the stem cell population and should allow an in-depth understanding of their biology. (C)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11860270     DOI: 10.1006/mcne.2001.1084

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  12 in total

Review 1.  Nonviral gene transfection nanoparticles: function and applications in the brain.

Authors:  Indrajit Roy; Michal K Stachowiak; Earl J Bergey
Journal:  Nanomedicine       Date:  2008-03-03       Impact factor: 5.307

2.  Gene transfer into primary cultures of fetal neural stem cells by a recombinant adenovirus carrying the gene for green fluorescent protein.

Authors:  Yong Fu; Shen-qing Wang; Ying-peng Liu; Guo-peng Wang; Jian-ting Wang; Shu-sheng Gong
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

3.  Enhanced selective gene delivery to neural stem cells in vivo by an adeno-associated viral variant.

Authors:  Melissa A Kotterman; Tandis Vazin; David V Schaffer
Journal:  Development       Date:  2015-05-15       Impact factor: 6.868

4.  Non-viral Vector Mediated RNA Interference Technology for Central Nerve System Injury.

Authors:  Christian Macks; Jeoung Soo Lee
Journal:  DNA RNA Nanotechnol       Date:  2016-08-25

5.  Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone.

Authors:  Ester J Kwon; Jurate Lasiene; Berit E Jacobson; In-Kyu Park; Philip J Horner; Suzie H Pun
Journal:  Biomaterials       Date:  2009-12-09       Impact factor: 12.479

Review 6.  Intrathecal drug delivery in the era of nanomedicine.

Authors:  M J Fowler; J D Cotter; B E Knight; E M Sevick-Muraca; D I Sandberg; R W Sirianni
Journal:  Adv Drug Deliv Rev       Date:  2020-03-03       Impact factor: 15.470

7.  Efficacy of nonviral gene transfer in the canine brain.

Authors:  Seunguk Oh; G Elizabeth Pluhar; Elizabeth A McNeil; Kurt M Kroeger; Chunyan Liu; Maria G Castro; Pedro R Lowenstein; Andrew Freese; John R Ohlfest
Journal:  J Neurosurg       Date:  2007-07       Impact factor: 5.115

8.  In Vivo Selection of a Computationally Designed SCHEMA AAV Library Yields a Novel Variant for Infection of Adult Neural Stem Cells in the SVZ.

Authors:  David S Ojala; Sabrina Sun; Jorge L Santiago-Ortiz; Mikhail G Shapiro; Philip A Romero; David V Schaffer
Journal:  Mol Ther       Date:  2017-09-08       Impact factor: 11.454

Review 9.  In vivo methods for acute modulation of gene expression in the central nervous system.

Authors:  Andrzej W Cwetsch; Bruno Pinto; Annalisa Savardi; Laura Cancedda
Journal:  Prog Neurobiol       Date:  2018-04-22       Impact factor: 11.685

10.  Efficient CPP-mediated Cre protein delivery to developing and adult CNS tissues.

Authors:  Yorick Gitton; Lorenzo Tibaldi; Edmond Dupont; Giovanni Levi; Alain Joliot
Journal:  BMC Biotechnol       Date:  2009-04-24       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.